The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity

July 17, 2025 updated by: Dara Mendez, University of Pittsburgh

The goal of this study is to learn about the effects of structural inventions, such as equity-focused Medicaid polices, on severe maternal morbidity (SMM) and mortality and maternal health. The main questions it aims to answer are:

  1. What is the effect of Medicaid healthcare quality interventions on SMM?
  2. What is the effect of Medicaid healthcare quality interventions + doula care?
  3. What are Medicaid beneficiaries' experiences in receiving services and the potential impact of integration of doula services and equity practices?

Participants will be asked to describe experiences as a result of structural interventions and focused Medicaid policies.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

10000000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15261
        • Recruiting
        • University of Pittsburgh School of Public Health
        • Contact:
        • Principal Investigator:
          • Dara D Mendez, PhD
        • Sub-Investigator:
          • Marian P Jarlenski, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Pregnant and postpartum Medicaid beneficiaries across the US

Qualitative:

  • Medicaid beneficiaries who self-identify as Black and/or live in PA Health Equity Zones
  • Doulas who provide care to Medicaid beneficiaries in Pennsylvania
  • Medicaid Managed Care Organization (MCO) administrators in Pennsylvania. Severe maternal morbidity and mortality outcomes will be assessed in healthcare records and for these quantitative outcomes, patients will not be recruited individually

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Care
Other: Medicaid healthcare quality interventions (equity payment and obstetric bundled payment) Only
The investigators will employ a quasi-experimental study design to test two hypotheses: H1: SMM rates among Black people will decline after the interventions (equity payment and obstetric bundled payment), relative to people of other race groups within Pennsylvania (PA); and H2: Racial inequities in SMM will decline among those exposed to the interventions in PA, relative to those in similar states. The investigators will collect qualitative data to assess the effects of the Medicaid healthcare interventions on beneficiaries' experiences.

This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2.

1) health equity incentive payment program makes available $26 million annually in Medicaid managed care organization (MCO) payments to plans that improve access to timely prenatal care and well-child visits among Black beneficiaries. The equity-focused obstetric care bundled payment model provides incentives for clinicians to improve on a wide range of pregnancy health outcomes, and specifically incentivizes improvements among Black beneficiaries

Participants receive standard care without quality interventions or doula care
Other: Doula Only
The investigators will test two hypotheses: H1: SMM rates among Black people will decline more after the addition of doula care in PA, relative to healthcare quality interventions alone. H2: Racial inequities in SMM will decline more among those exposed to both healthcare quality and doula care interventions in PA, relative to states implementing doula care only. The investigators will collect qualitative data to assess the effects of the Medicaid healthcare and service interventions on beneficiaries' experiences.
Participants receive standard care without quality interventions or doula care

This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2.

  1. health equity incentive payment program makes available $26 million annually in Medicaid managed care organization (MCO) payments to plans that improve access to timely prenatal care and well-child visits among Black beneficiaries. The equity-focused obstetric care bundled payment model provides incentives for clinicians to improve on a wide range of pregnancy health outcomes, and specifically incentivizes improvements among Black beneficiaries.
  2. care intervention by coverage of doula services for all Medicaid beneficiaries across Pennsylvania.
Other: Medicaid healthcare quality interventions (equity payment and obstetric bundled payment) + Doula

This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2.

1) health equity incentive payment program makes available $26 million annually in Medicaid managed care organization (MCO) payments to plans that improve access to timely prenatal care and well-child visits among Black beneficiaries. The equity-focused obstetric care bundled payment model provides incentives for clinicians to improve on a wide range of pregnancy health outcomes, and specifically incentivizes improvements among Black beneficiaries

Participants receive standard care without quality interventions or doula care

This study has two components, with the first component being examined in Aim 1 and the first and second components being examine in aim 2.

  1. health equity incentive payment program makes available $26 million annually in Medicaid managed care organization (MCO) payments to plans that improve access to timely prenatal care and well-child visits among Black beneficiaries. The equity-focused obstetric care bundled payment model provides incentives for clinicians to improve on a wide range of pregnancy health outcomes, and specifically incentivizes improvements among Black beneficiaries.
  2. care intervention by coverage of doula services for all Medicaid beneficiaries across Pennsylvania.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severe maternal morbidity (SMM)
Time Frame: 20 weeks gestation through 42 days postpartum
SMM rate based on the Centers for Disease Control algorithm
20 weeks gestation through 42 days postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All cause mortality
Time Frame: Delivery date through one year after delivery
Binary indicator of mortality based on Social Security Administration records
Delivery date through one year after delivery
Follow up for chronic conditions
Time Frame: 43 days through 1 year after delivery
Percent of persons who receive guideline concordant care for depression, substance use disorders, immunizations, and screening and referral for social determinants of health
43 days through 1 year after delivery
Provision of evidence care in pregnancy and postpartum
Time Frame: During pregnancy and postpartum up to 1 year
Percent of Medicaid patients among each provider who receive screening and follow up for depression, treatment for substance use disorders, perinatal immunizations, and screening and referral for social determinants of health
During pregnancy and postpartum up to 1 year
Medicaid managed care administrator perspectives on policy interventions
Time Frame: Year 3
Qualitative self report of perspectives
Year 3

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess the changes in effects of the Medicaid healthcare quality interventions on beneficiaries' experiences
Time Frame: Years 2, 3, and 4
The investigators will collect qualitative data from three different study populations across Pennsylvania who will be affected by the Medicaid policies under study: 1) Medicaid beneficiaries (n=100; Years 2 and 4); 2) Doula care providers (n=60; Years 2 and 4); Managed Care Organization (MCO) leadership (n=10); Year 3
Years 2, 3, and 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2023

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

October 26, 2022

First Submitted That Met QC Criteria

December 22, 2022

First Posted (Actual)

January 10, 2023

Study Record Updates

Last Update Posted (Actual)

July 22, 2025

Last Update Submitted That Met QC Criteria

July 17, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY22080184
  • 1R01NR020670-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maternal Death

Subscribe